MoonLake Immunotherapeutics (MLTX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -66.29M | -58.79M | -44.54M | -54.53M | -38.14M | -48.47M | -25.28M | -27.89M | -14.95M | -12.34M | -9.25M | -12.16M | -9.02M | -11.6M | -9.35M | -34.15M | -14.19M | -7.45M | -2.02M | 6.14K |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -73.8% | -21.29% | -76.23% | -95.52% | -155.15% | -292.68% | -173.23% | -129.38% | -65.64% | -6.45% | 1.08% | 64.4% | 36.38% | -55.61% | -363.27% | -556336.04% | -13060.13% | - | - | - |
| Net Income | -69.71M | -63.02M | -70.69M | -56.05M | -40.56M | -45.6M | -36.11M | -24.76M | -13.97M | -7.44M | -11.62M | -12.35M | -12.22M | -16.47M | -14.74M | -12.12M | -15.88M | -14.32M | -6.29M | -32.69M |
| Depreciation & Amortization | 845K | 751K | 745K | 742K | 378K | 1.3M | -586.56K | 342K | 328K | 3.29K | 3.29K | 3.29K | 3.29K | 3.29K | 3.29K | 0 | 2.49K | 2.49K | 2.27K | 0 |
| Stock-Based Compensation | 13.36M | 3.59M | 3.71M | 3.31M | 2.29M | 0 | 1.84M | 1.83M | 1.68M | 1.61M | 1.43M | 1.5M | 2.58M | 2.6M | 2.59M | 0 | 1.99M | 0 | 1.86M | 1.25M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37.47K | -23.96K | -13.51K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 433K | 252K | 265K | -1.34M | 120K | -269.75K | 1.3M | 19K | -133K | -16.07K | -46.99K | -33.28K | 45.53K | 150.3K | 49.89K | -13.81M | 81.96K | 5.86M | 155.63K | 31.44M |
| Working Capital Changes | -11.21M | -369K | 21.43M | -1.19M | -369K | -3.9M | 8.28M | -5.32M | -2.85M | -6.54M | 1.01M | -1.26M | 568.55K | 2.12M | 2.75M | -8.22M | -379.14K | 1M | 2.26M | 0 |
| Change in Receivables | -894K | -146K | -612K | -420K | -146K | -436.14K | -730.2K | -181K | -439K | -336.11K | -100.99K | -241.32K | -161.32K | 383.41K | -43 | 0 | -432.8K | 0 | -56.03K | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 98K | -29.91M | 88.4M | 88.25M | 56.25M | -147.33M | 58.28M | -87.74M | -28.8M | 116.87M | -174.38M | 12.68M | 19.65M | 9.9M | -42.23M | -16.01K | -16.01K | -18.38K | -11.65K | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | -35K | -175.57K | -131.95K | 0 | -212K | -284.63K | 0 | 0 | 0 | -1 | 0 | -16.01K | -16.01K | -18.38K | -11.65K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 175.56B | -174.38K | 12.68K | 19.65K | 9.9M | -42.23K | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 30.64M | 72.39M | 480K | 0 | 73.12M | 150.71K | 183K | 0 | 50.98M | 28.42M | 0 | 451.29M | 0 | 3.79K | 0 | 18.54M | 15M | 15M | 498.33K | 0 |
| Debt Issued (Net) | 24.47M | 0 | 0 | 0 | 73.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.15M | 15M | 15M | 0 | 0 |
| Equity Issued (Net) | 6.18M | 72.39M | 0 | 0 | 100K | 150.71K | 140 | 0 | 52.54M | 31.17M | 0 | 451.29M | 0 | 0 | 0 | 134.69M | 0 | 2.08K | 495.05K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.2K | 0 | 0 |
| Other Financing | 0 | 0 | 480K | 0 | 0 | 0 | 182.86K | 0 | -1.56M | -2.75M | 0 | 0 | 0 | 3.79K | 0 | -101M | 3.79K | -3.28K | 3.28K | 0 |
| Net Change in Cash | -36.03M | -16.22M | 44.05M | 35.12M | 91.14M | -195.23M | 32.87M | -115.65M | 7.27M | 133M | -183.62M | 451.66M | 10.62M | -1.7M | -51.5M | -8.32M | 795.31K | 7.01M | -1.53M | 6.14K |
| Free Cash Flow | -66.29M | -58.79M | -44.54M | -54.53M | -38.17M | -48.65M | -25.41M | -27.89M | -15.16M | -12.63M | -9.25M | -12.16M | -9.02M | -11.6M | -9.35M | -34.17M | -14.2M | -7.47M | -2.03M | 6.14K |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -73.64% | -20.85% | -75.31% | -95.52% | -151.81% | -285.22% | -174.66% | -129.38% | -67.99% | -8.91% | 1.08% | 64.42% | 36.46% | -55.23% | -360.61% | -556596.74% | -13074.98% | - | - | - |
| FCF per Share | -0.93 | -0.91 | -0.70 | -0.86 | -0.60 | -0.77 | -0.40 | -0.44 | -0.24 | -0.21 | -0.17 | -0.28 | -0.23 | -0.30 | -0.25 | -0.97 | -0.38 | -0.20 | -0.05 | 0.00 |
| FCF Conversion (FCF/Net Income) | 0.95x | 0.94x | 0.64x | 0.99x | 0.95x | 1.06x | 0.71x | 1.15x | 1.09x | 1.66x | 0.98x | 1.20x | 1.00x | 5.99x | 0.92x | 2.82x | 0.89x | 0.52x | 0.32x | -0.00x |
| Interest Paid | 0 | 0 | 1.72M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |